5-phenylcarbamoyl-pentanoic acid | 34413-03-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-phenylcarbamoyl-pentanoic acid
• 英文别名: 6-oxo-6-(phenylamino)hexanoic acid；6-Anilino-6-oxohexanoic acid；Adipanilic acid
• CAS: 34413-03-1
• 化学式: C₁₂H₁₅NO₃
• 分子量: 221.256
• InChiKey: GJDYPQDCMXGZAT-UHFFFAOYSA-N

物化性质

• 熔点：
  152.0-153.0 °C
• 沸点：
  476.8±28.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090

反应信息

• 作为反应物：
  描述：

  5-phenylcarbamoyl-pentanoic acid 在 palladium on activated charcoal 二苯基膦叠氮化物 、 氢气 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 苯 为溶剂， 生成 5-[(2-溴乙酰基)氨基]-N-苯基戊酰胺
  参考文献：
  名称：

  Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates

  摘要：

  In order to find novel non-hydroxamate histone deacetylase (HDAC) inhibitors, a series of compounds modeled after suberoylanilide hydroxamic acid (SAHA) were designed and synthesized as (i) substrate (acetyl lysine) analogues (compounds 3-7), (ii) analogues bearing various functional groups expected to chelate zinc ion (compounds 8-15), and (iii) analogues bearing nucleophilic functional groups which could bind covalently to HDACs (compounds 16-18). In this series, semicarbazide 8b and bromoacetamides 18b,c were found to be potent HDAC inhibitors for non-hydroxamates. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.09.048
• 作为产物：
  描述：

  甲基脂肪酰氯 在 lithium hydroxide 、 N,N-二异丙基乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 3.67h， 生成 5-phenylcarbamoyl-pentanoic acid
  参考文献：
  名称：

  基于巯基酰胺的非异羟肟酸型组蛋白脱乙酰基酶抑制剂。

  摘要：

  组蛋白脱乙酰基酶（HDAC）的抑制剂正在作为一种有前途的抗癌药出现。将巯基酰胺官能团设计为双齿锌螯合剂，并掺入基于异羟肟酸的SAHA（1）支架中，以鉴定非异羟肟酸酯化合物作为组蛋白脱乙酰基酶的潜在抑制剂。合成了两组具有不同间隔长度的巯基酰胺2和3，并评估了其对HDAC的抑制活性。巯基酰胺2e，3b和3d的微摩尔抑制作用较低。

  DOI：

  10.1016/j.bmcl.2005.02.075

文献信息

• Metal‐Free Synthesis of <i>N</i> ‐Aryl Amides using Organocatalytic Ring‐Opening Aminolysis of Lactones
  作者：Wusheng Guo、José Enrique Gómez、Luis Martínez‐Rodríguez、Nuno A. G. Bandeira、Carles Bo、Arjan W. Kleij

  DOI：10.1002/cssc.201700415

  日期：2017.5.9

  Catalytic ring‐opening of bio‐sourced non‐strained lactones with aromatic amines can offer a straightforward, 100 % atom‐economical, and sustainable pathway towards relevant N‐aryl amide scaffolds. Herein, the first general, metal‐free, and highly efficient N‐aryl amide formation is reported from poorly reactive aromatic amines and non‐strained lactones under mild operating conditions using an organic

  生物来源的非应变内酯与芳族胺的催化开环可以提供一种直接的，100％原子经济且可持续的通往相关N芳基酰胺支架的途径。在此，据报道，在温和的操作条件下，使用有机双环胍催化剂，由反应性较差的芳族胺和非应变的内酯首次形成了无金属且高效的N-芳基酰胺。该协议具有很高的应用潜力，例如与药物相关的分子的形式合成。
• [EN] 2-AMINO-1,3,4-THIADIAZINE AND 2-AMINO-1,3,4-OXADIAZINE BASED ANTIFUNGAL AGENTS<br/>[FR] AGENTS ANTIFONGIQUES À BASE DE 2-AMINO-1,3,4-THIADIAZINE ET DE 2-AMINO-1,3,4-OXADIAZINE
  申请人：F2G LTD

  公开号：WO2017009651A1

  公开（公告）日：2017-01-19

  The invention provides a compound which is a diazine of formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt thereof, for use as an antifungal agent: (I) wherein X, N', C', A and E are as defined herein. The invention also provides a compound of Formula (I) as defined herein.

  该发明提供了一种化合物，其为式(I)的二氮杂环化合物或其互变异构体，或其药学上可接受的盐，用作抗真菌剂：(I)其中X、N'、C'、A和E如本文所定义。该发明还提供了一种如本文所定义的式(I)的化合物。
• Beyond the Five and Six: Evaluation of Seven-Membered Cyclic Anhydrides in the Castagnoli–Cushman Reaction
  作者：Mykhailo I. Adamovskyi、Sergey V. Ryabukhin、Dmitriy A. Sibgatulin、Eduard Rusanov、Oleksandr O. Grygorenko

  DOI：10.1021/acs.orglett.6b03426

  日期：2017.1.6

  method worked with imines generated from aromatic or α-branched aliphatic aldehydes and is amenable for both parallel synthesis and scale-up. The procedure for epimerization of the resulting trans-disubstituted tetrahydrobenzo[d]azepines to their cis isomers was also developed.

  与苯并[ d ]氧杂环庚烷-2,4（1 H，5 H）-二酮作为酸酐组分的Castagnoli–Cushman反应可用于制备2,3-二取代的4-氧代-2,3,4,5-四氢呋喃-1 H-苯并[ d ]氮杂-1-羧酸的产率为21–75％，反式非对映选择性良好。该方法适用于由芳族或α-支化脂族醛生成的亚胺，适用于平行合成和放大。还开发了将所得的反式-二取代的四氢苯并[ d ]氮杂环庚烷异构化成其顺式异构体的方法。
• GEMCITABINE PRODRUGS AND USES THEREOF
  申请人：BoYen Therapeutics, Inc.

  公开号：US20140134160A1

  公开（公告）日：2014-05-15

  The present invention provides compounds according to formula I: and pharmaceutically acceptable salts thereof. For compounds of formula I, R 1 and R 2 are independently selected from the group consisting of H, —C(═O)—(CH 2 ) 2 -aryl, and —C(═O)—(CH 2 ) n —C(═O)—NH-aryl. The subscript n is from 2 to 6. R 3 is selected from the group consisting of H and —C(═O)—O—R 4 ; and R 4 is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, arylalkyl, substituted arylalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl and substituted heteroalkyl. Compounds are provided wherein at least one of R 1 and R 2 is other than H. Pharmaceutical compositions, methods for inhibiting the growth of cancer cells, and methods for the treatment of cancer are also provided.

  本发明提供了公式I的化合物及其药学上可接受的盐。对于公式I的化合物，R1和R2独立地选择自H，—C（═O）—（CH2）2-芳基和—C（═O）—（ ）n—C（═O）—NH-芳基的群组。下标n为2至6。R3选择自H和—C（═O）—O—R4的群组；而R4选择自烷基，取代烷基，烯基，取代烯基，炔基，取代炔基，芳基烷基，取代芳基烷基，环杂芳基烷基，取代环杂芳基烷基，杂基和取代杂基的群组。提供了至少一个R1和R2不是H的化合物。还提供了制药组合物，抑制癌细胞生长的方法和治疗癌症的方法。
• Highly Chemoselective Transamidation of Unactivated Tertiary Amides by Electrophilic N−C(O) Activation by Amide‐to‐Acyl Iodide Re‐routing
  作者：Dongxu Zuo、Qun Wang、Long Liu、Tianzeng Huang、Michal Szostak、Tieqiao Chen

  DOI：10.1002/anie.202202794

  日期：2022.6.13

  The challenging transamidation of unactivated tertiary amides using equivalent amounts of amines has been accomplished via cooperative acid/iodide catalysis. The method provides a novel manifold to re-route the reactivity of unactivated and unreactive N,N-dialkyl amides through reactive acyl iodide intermediates, representing a powerful new activation mode of unactivated amide bonds.

  使用等量的胺对未活化的叔酰胺进行具有挑战性的转酰胺化反应是通过协同酸/碘化物催化完成的。该方法提供了一种新的方法，通过反应性酰碘中间体重新引导未活化和未反应性N,N-二烷基酰胺的反应性，代表了一种强大的未活化酰胺键的新活化模式。